✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

Gland Pharma Ltd.

GLAND

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹32,751 Cr.
P/E
42.52

Gland Pharma Ltd.

Key Ratios

Edit Ratio's
Market cap
Market cap
32,751 Cr
PE
PE
42.52
Prom Holding
Prom Holding
51.83 %
ROE (%)
ROE (%)
7.63
ROCE (%)
ROCE (%)
11.50
Div Yield (%)
Div Yield (%)
0.91
Sales
Sales
5,720 Cr
OPM (%)
OPM (%)
23.99 %
Debt to Equity
Debt to Equity
0.03
View more
Edit Ratio's

About

Gland Pharma Limited specializes in providing a range of injectable products in therapeutic ar… Read more
Low
1278
52W Range
High
2131
  • Gland Pharma
  • Caplin Point Lab
  • Gufic Biosciences
  • TJI Pharma - API & CRAMS

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statement

New
Edit rows

Forensics

8 Yes

Positive for this company

3 Neutral

Neutral for this company

6 No

Negative for this company

0 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Distribution Channel

Operational Metrics

    locked
    Select a Metric
    • Number of ANDA's Filed in USA (.)
      Source
    • Number of ANDA's Approved By USFDA (.)
      Source
    • US DMF Filings (.)
      Source
    • R&D as a % of Total Sales (%)
      Source
    • API Capacity (Kg/Year)
      Source

    Peer Comparison

    Corporate Actions

    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less

    Suppliers

    • Mold-Tek Technologies Ltd.

    FAQs on Gland Pharma Ltd. Business

    Gland Pharma Limited focuses on providing affordable and high-quality injectables across various therapeutic areas and delivery systems including complex injectables and new delivery systems like pens and cartridges.

    Gland Pharma major competitors are Caplin Point Lab, Gufic Biosciences, Ipca Laboratories, Ajanta Pharma, JB Chem & Pharma, Wockhardt, Pfizer.
    Market Cap of Gland Pharma is ₹33,302 Crs.
    While the median market cap of its peers are ₹25,164 Crs.

    Gland Pharma seems to be less financially stable compared to its competitors.
    Altman Z score of Gland Pharma is 12.29 and is ranked 5 out of its 8 competitors.

    View FAQ's On Shareprice

    Company Filing

    2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release May Aug Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Dec
    Investor Presentation May Aug Feb Mar Jun Sep Dec Mar Jun Sep Dec Mar May Jun Jul Sep Dec Jan Mar Jun Sep Dec Dec
    Conference Call Mar Jun Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Dec
    Conference Call SummaryCon Call Summary

    Discussions & Analysis

    Gland Pharma Ltd.
    Complete Analysis of Gland Pharma - Sadhan
    Gland Pharma Analysis - Pure play injectables player - Value Educator
    View the discussion on ValuePickr
    Corporate Governance Red Flags At Gland Pharma - Beat The Street
    The Business Risk Of Gland Pharma According to Aditya Khemka - Incred
    Ideas Dashboard
    Results
    Timeline
    Watchlist
    Portfolio
    Alerts
    Stock Screener
    Market
    Raw Material